![A clinical trial protocol for the study of intravenous immunoglobulin in patients with primary antibody immunodeficiency disorders A clinical trial protocol for the study of intravenous immunoglobulin in patients with primary antibody immunodeficiency disorders](https://lymphosign.com/cms/10.14785/lymphosign-2016-0005/asset/images/lymphosign-2016-0005tab2.gif)
A clinical trial protocol for the study of intravenous immunoglobulin in patients with primary antibody immunodeficiency disorders
![Efficacy of high-dose intravenous immunoglobulin in severe and critical COVID-19: A retrospective cohort study - ScienceDirect Efficacy of high-dose intravenous immunoglobulin in severe and critical COVID-19: A retrospective cohort study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1567576922000996-gr1.jpg)
Efficacy of high-dose intravenous immunoglobulin in severe and critical COVID-19: A retrospective cohort study - ScienceDirect
![Effectiveness of high‐dose i.v. immunoglobulin therapy for pregnant women with aspirin–heparin‐resistant secondary antiphospholipid syndrome - Maesawa - 2018 - Reproductive Medicine and Biology - Wiley Online Library Effectiveness of high‐dose i.v. immunoglobulin therapy for pregnant women with aspirin–heparin‐resistant secondary antiphospholipid syndrome - Maesawa - 2018 - Reproductive Medicine and Biology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/653eda0e-9770-4d7e-a6f9-557fe9b2711b/rmb212080-toc-0001-m.jpg?trick=1659669784536)
Effectiveness of high‐dose i.v. immunoglobulin therapy for pregnant women with aspirin–heparin‐resistant secondary antiphospholipid syndrome - Maesawa - 2018 - Reproductive Medicine and Biology - Wiley Online Library
Evaluating Dose Ratio of Subcutaneous to Intravenous Immunoglobulin Therapy Among Patients With Primary Immunodeficiency Disease Switching to 20% Subcutaneous Immunoglobulin Therapy
![Frontiers | Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe Frontiers | Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe](https://www.frontiersin.org/files/Articles/122822/fimmu-05-00629-HTML/image_m/fimmu-05-00629-t012.jpg)
Frontiers | Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe
![A 10% liquid immunoglobulin preparation for intravenous use (Privigen®) in paediatric patients with primary immunodeficiencies and hypersensitivity to IVIG | Allergologia et Immunopathologia A 10% liquid immunoglobulin preparation for intravenous use (Privigen®) in paediatric patients with primary immunodeficiencies and hypersensitivity to IVIG | Allergologia et Immunopathologia](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S0301054612002716:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNe5umqYt0zKZP4SYniTZ7+SgZrkCgayp3MRA1ovxa2vU3O809uy5IBFIjRXKUBlhiAtEh81Ml1AI9Bisd8qzUkfOjuQG8fIYLeffgysBZ3UKK0jF7nbONfawtIR/cElRly8L5L1om74+4XDR81fUxBGarPonfgWJhzbQPMersWc0nRqsq5Q7LBnWKNqSYc+E5avwnYndLtXEa50XRZ0DZ3g2yAIIaN1ayoXR/70jpOayMz5+Ie8b36oMNC5rIIluFjvgAETrrZGqcE4J+Hpwn22)
A 10% liquid immunoglobulin preparation for intravenous use (Privigen®) in paediatric patients with primary immunodeficiencies and hypersensitivity to IVIG | Allergologia et Immunopathologia
![Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial - The Lancet Neurology Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c64fcd79-b3d0-4d68-94aa-3eaae4c41f21/gr1.gif)
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial - The Lancet Neurology
![An Overview of Intravenous and Subcutaneous Immunoglobulin (IVIG/SCIG) In Neurology — BioMatrix Specialty Pharmacy An Overview of Intravenous and Subcutaneous Immunoglobulin (IVIG/SCIG) In Neurology — BioMatrix Specialty Pharmacy](https://images.squarespace-cdn.com/content/v1/58d944d2ebbd1aac620cfead/1595348701852-HZ2V1OZPBMQCSVC8ULU6/Chart-4.jpg?format=1000w)
An Overview of Intravenous and Subcutaneous Immunoglobulin (IVIG/SCIG) In Neurology — BioMatrix Specialty Pharmacy
![Therapeutic Effect of IVIG on Inflammatory Arthritis in Mice Is Dependent on the Fc Portion and Independent of Sialylation or Basophils | The Journal of Immunology Therapeutic Effect of IVIG on Inflammatory Arthritis in Mice Is Dependent on the Fc Portion and Independent of Sialylation or Basophils | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/192/11/5031/F1.large.jpg)